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Light is the most potent stimulus for synchro-
nizing endogenous circadian rhythms with ex-
ternal time. Photic clock resetting in mammals
involves cAMP-responsive element binding
protein (CREB)-mediated transcriptional acti-
vation of Period clock genes in the suprachias-
matic nuclei (SCN). Here we provide evidence
for an additional photic input pathway to the
mammalian circadian clock based on Protein
Kinase C a (PRKCA). We found that Prkca-
deficient mice show an impairment of light-
mediated clock resetting. In the SCN of wild-
type mice, light exposure evokes a transient
interaction between PRKCA and PERIOD 2
(PER2) proteins that affects PER2 stability and
nucleocytoplasmic distribution. These post-
translational events, together with CREB-
mediated transcriptional regulation, are key
factors in the molecular mechanism of photic
clock resetting.
INTRODUCTION
Endogenous self-sustained clocks with a period of about
24 hr drive the rhythms of all physiological processes that
are subject to circadian variation (Panda et al., 2002; Re-
ppert and Weaver, 2002). In mammals, the master circa-
dian pacemaker resides in the suprachiasmatic nuclei
(SCN) of the hypothalamus (Ralph et al., 1990). Several
key components of the molecular clockwork have been
identified through a combination of genetic and biochem-
ical studies (reviewed by Lowrey and Takahashi, 2004). At
the basis of the circadian clockwork lies a network of inter-
locked transcriptional and translational feedback loops
(TTLs). Positive regulatory elements are BMAL1 and
CLOCK (or a related protein; see Debruyne et al., 2006)that heterodimerize and activate the transcription of
Period (Per1 and Per2) and Cryptochrome (Cry1 and
Cry2) genes through binding to E-box enhancer elements
(Gekakis et al., 1998; Jin et al., 1999; Kume et al., 1999).
The PER and CRY proteins interact and translocate to
the nucleus, where they shut down their own transcription
by inhibiting the CLOCK/BMAL1 transcriptional activator
complex (Kume et al., 1999). Another facet of the TTL in-
volves the nuclear orphan receptors REV-ERBa (NR1D1)
(Preitner et al., 2002) and RAR-related orphan receptor
a (RORA, NR1F1) (Sato et al., 2004) that control the
expression of the Bmal1 gene.
A hallmark of the mammalian circadian pacemaker is its
ability to be reset by light, thus allowing organisms to en-
train to temporal variations of natural light conditions. A
light pulse perceived after dusk will delay the pacemaker,
while a pulse applied before dawn will advance the clock.
Photic stimuli are transmitted from the retina to target
neurons in the SCN, where they are transduced to the
molecular clockwork through kinase cascades involving
activation of type A and G kinases, calcium-calmodulin
protein kinase, and mitogen-activated protein kinases
(Butcher et al., 2002; Obrietan and van den Pol, 1998;
Oster et al., 2003; Tischkau et al., 2000; Yokota et al.,
2001). These signaling pathways converge on the cAMP-
responsive element binding protein (CREB) that becomes
phosphorylated at Ser133 and Ser142. Such phosphory-
lation activates CREB, which subsequently translocates
to the nucleus and binds to cAMP-responsive elements
located in the promoters of light-responsive genes includ-
ing Per1 and Per2 (Ding et al., 1997; Gau et al., 2002; Ginty
et al., 1993; Obrietan et al., 1999; Travnickova-Bendova
et al., 2002). The TTL model predicts that CREB-mediated
transcriptional activation of Per genes followed by an in-
crease in PER proteins (Yan and Silver, 2004; although
see Field et al., 2000) shifts the clock. At the behavioral
level altered expression of clock genes is correlated with
changes in locomotor activity rhythms.
It is well established that posttranslational mechanisms
like phosphorylation and protein interactions are criticalNeuron 54, 831–843, June 7, 2007 ª2007 Elsevier Inc. 831
Neuron
PRKCA in Mammalian Clock Resettingfor light-mediated regulation of the core clock. In
Drosophila light induces binding of activated CRY to
TIMELESS (TIM) protein (Busza et al., 2004; Ceriani
et al., 1999; Naidoo et al., 1999). TIM is then phosphory-
lated, enabling JETLAG to target TIM for degradation
through the proteasome pathway (Koh et al., 2006).
Thus, in dipterans photic entrainment involves posttran-
scriptional events, while in mammals it is apparently regu-
lated at the transcriptional level via CREB.
The mammalian protein kinase C (PRKC) family com-
prises three subfamilies: classical, novel, and atypical
(Parker and Murray-Rust, 2004). All of the three classical
PRKCs (PRKCA, PRKCB1/2, PRKCG; previously known
as PKCa, bI/II, and g) are activated by binding of diacylgly-
cerol and Ca2+ to the regulatory domain of the kinase. This
results in the release of a pseudosubstrate site from the
substrate binding cavity and subsequently allows sub-
strate protein binding and phosphorylation (Nakashima,
2002; Newton, 2003; Parekh et al., 2000). Several PRKCS
are expressed in the SCN of mice, including PRKCA (Van
der Zee and Bult, 1995). Pharmacological PRKC inhibitors
and activators both evoke phase advances of neuronal
firing rhythms in hamster SCN slice cultures (Schak and
Harrington, 1999). Although these studies do not uncover
the mechanism of action of PRKCs in the circadian clock,
they raise the possibility that classical PRKCs have a role
in the mammalian circadian timing system. We tested this
hypothesis by taking advantage of the Prkca-deficient
mouse and show that PRKCA is a light-controlled post-
translational regulator of PER2 stability and subcellular
localization.
RESULTS
Prkca-Deficient Mice Display an Impaired Resetting
of the Circadian Clock
As basal PRKC activity in rat suprachiasmatic nucleus-
derived SCN2.2 cells follows a rhythmic pattern peaking
between CT14 and CT22 (Rivera-Bermudez et al., 2003),
and as PRKCA expression is elevated at CT14 in the
SCN of rat (Cagampang et al., 1998), we first investigated
whether transcription of the Prkca gene is under circadian
control. To this end, wild-type mice maintained either in
a regular 12 hr light/12 hr dark cycle (LD 12:12) or in con-
stant darkness (DD) were sacrificed at different times and
the level of Prkca expression in the SCN was determined
by in situ hybridization (ISH). Quantification of the ISH
signal revealed a substantial daily variation of Prkca
transcript levels, both under LD and DD conditions, with
maxima at the beginning of the activity phase (Figures
1A and 1B). The persistence of rhythmic expression in
DD demonstrates that Prkca transcription is under endog-
enous clock control, rather than being driven by the envi-
ronmental light/dark cycle.
Since rhythmic expression of Prkca in the SCN is driven
by the circadian core oscillator, we examined Prkca-
deficient mice for defects in the circadian control of loco-
motor activity. Such mice are devoid of PRKCA protein,832 Neuron 54, 831–843, June 7, 2007 ª2007 Elsevier Inc.but are morphologically normal, viable, and fertile (Leitges
et al., 2002). Following entrainment to an LD 12:12 cycle,
Prkca/ mice and congenic wild-type controls were
released into DD. In LD, all animals displayed normal
entrainment with activity onsets at the beginning of the
dark phase. When released into DD, both wild-type and
mutant mice showed a persistent endogenous activity
rhythm with comparable period lengths (t) of 23.70 ±
0.07 hr (mean ± SEM) for wild-type animals and 23.76 ±
0.05 hr for Prkca/mice (Figures 2A and 2B). In constant
light conditions (LL) t is known to increase in nocturnal
animals (Aschoff, 1979). In wild-type controls t was
25.18 ± 0.11 hr in LL of 100 lux, but the average circadian
Figure 1. Rhythmic Expression of Prkca mRNA in the SCN
Upper panels show autoradiographs of Prkca expression in the SCN
under LD (A) or DD (B) conditions. Graphs depict densitometric quan-
tification of the ISH signal. White/gray and black horizontal bars indi-
cate (subjective) day and night, respectively. All data are presented
as mean ± SEM for three different experiments. Scale bars, 200 mm.
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PRKCA in Mammalian Clock Resettingperiod of Prkca-deficient animals was significantly shorter
than that of wild-type controls (24.91 ± 0.08 hr) under
these conditions (Figures 2C and 2D). The impairment of
lengthening of t in LL provided a first indication that the
regulation of the circadian clock by light is abnormal in
the absence of PRKCA.
This prompted us to test whether Prkca/mice exhibit
an abnormal response toward short nocturnal light pulses
that are capable of resetting the phase of the endogenous
clock. Sample actograms (Figures 2E and 2F) and phase
response curves (Figure 2G) reveal that wild-type and
Prkca/ animals displayed similar phase-shifting re-
sponses to light pulses. However, significant quantitative
differences were observed in the magnitude of phase de-
lays. Exposure to a light pulse at ZT14 (2 hr after ‘‘lights
off’’) caused a delay of 1.01 ± 0.1 hr in wild-type animals;
the phase-shifting response of Prkca/ mice was only
0.52 ± 0.09 hr. In contrast, a light pulse given 10 hr after
lights off (ZT22, toward the end of the activity phase) led
to comparable phase advances in wild-type (0.61 ±
0.11 hr) and Prkca/mice (0.45 ± 0.03 hr). The restriction
of the altered light response to the first half of the activity
phase may reflect the fact that Prkca expression is down-
regulated toward the end of the activity period (Figure 1).
Light-Induced Transcriptional Activation of Core
Clock Genes Is Not Affected in Prkca-Deficient Mice
Since the phase-delay phenotype of Prkca-deficient mice
is reminiscent of that seen in CREBS142A point mutant
mice (Gau et al., 2002), the most parsimonious explana-
tion of the Prkcamutant data is to assume that the kinase
is impinging on the CREB pathway. To investigate this
possibility, we examined the induction of the light-induc-
ible clock genes Per1, Per2, and Dec1 (Shearman et al.,
1997; Albrecht et al., 1997; Honma et al., 2002) in
Prkca/ mice. As expected, Per1, Per2, and Dec1 gene
expressions were strongly induced in the SCN of light-
exposed wild-type mice (Figure 3). Surprisingly, this was
also the case for Prkca-deficient animals, as evident
from the absence of differences in magnitude or localiza-
tion of gene induction between wild-type and mutant
animals. This result makes a participation of PRKCA in
CREB-mediated clock gene activation less likely, and in-
stead strongly suggests the involvement of an additional,
as of yet unknown pathway by which light can regulate the
circadian clock.
PRKCA Can Bind and Phosphorylate PER2
A number of clock proteins have been shown to interact
with kinases, which indicates that phosphorylation plays
a key role in the molecular mechanism of the circadian
core oscillator (Lowrey et al., 2000; Vanselow et al.,
2006; Gallego et al., 2006; Shim et al., 2007; Xu et al.,
2007). We therefore aimed at identifying clock protein
substrates that bind to, and are phosphorylated by,
PRKCA. We thus coexpressed PRKCA with Myc-tagged
PER2 (PER2Myc), V5-tagged CRY2 (CRY2V5), or both
in COS7 cells (Figure 4A). Notably, PER2 appears anattractive candidate target because it has been implicated
in the phase-delay mechanism (Albrecht et al., 2001;
Reppert and Weaver, 2001, but also see Bae andWeaver,
2003 for an alternative view), and Prkca-deficient mice
show a phase-delay phenotype. Immunoprecipitation
with PRKCA antibodies, followed by western blot analysis
using Myc antiserum, showed that PRKCA precipitates
together with PER2Myc protein (Figure 4A, lane 4). In con-
trast, CRY2V5 could not be pulled down with the kinase
antiserum when coexpressed with PRKCA alone (lane 5).
However, in line with the observation that PER proteins
strongly interact with cryptochromes (Chaves et al.,
2006; Griffin et al., 1999; Kume et al., 1999; Yagita et al.,
2002), a CRY2V5/PER2Myc/PRKCA complex could be
coprecipitated when all three proteins were expressed
together (lane 7).
We next asked whether PRKCA phosphorylates PER2
and CRY2 in vitro. To this end, PER2Myc and CRY2V5
were expressed in COS7 cells, and resulting proteins
were pulled down with antibodies against the Myc protein
tag. Thereafter, PER2Myc alone or PER2Myc/CRY2V5 were
incubated with recombinant PRKCA and 32P-ATP, as
detailed in the header of Figure 4B. A distinct radioactive
protein of 130 kDa was detected (Figure 4B, lane 1),
which was identified as PER2Myc by western blot analysis
using an anti-Myc antibody (data not shown). This band
was also seen when PER2Myc and CRY2V5 were both
present in the kinase assay, indicating that CRY2 does
not interfere with PER2 phosphorylation (lane 2). Addition
of the PRKC inhibitor bisindolylmaleimide resulted in an
almost complete inhibition of PER2 phosphorylation
(lanes 4 and 5). Phosphorylation of PER2 in the in vitro
kinase assay is mediated by added PRKCA rather than
by endogenous (copurified) kinases, since without exoge-
nous PRKCA, PER2 was not significantly phosphorylated
(Figure 4C). CRY2V5, either alone or in the presence of
PER2Myc, appears not to be subject to PRKCA-mediated
phosphorylation (lanes 2 and 3; expression of CRY2V5
was verified by western blot analysis using V5 antibodies,
data not shown). Taken together, these cell-based assays
suggest that PRKCA engages in a direct interaction with
PER2, but not with CRY2, and that CRY2 was pulled
down because of its association with PER2. Moreover,
PRKCA phosphorylates PER2, but not CRY2. When both
clock proteins were mixed together, presumably resulting
in heterodimers (Field et al., 2000; Hogenesch et al., 1998;
Kume et al., 1999), PER2 was also phosphorylated.
Photic Control of the Interaction between PRKCA
and PER2 in the SCN
We next examined whether the interaction between
PRKCA and PER2, as observed in COS7 cells, also occurs
in the SCN, and more importantly, whether this interaction
is influenced by light, as could be expected from the im-
paired light-resetting phenotype of Prkca/ mice. To
this end, we exposed mice to light pulses at ZT14, the
time at which the difference in phase shift responses be-
tween wild-type and mutant mice is largest. ProteinNeuron 54, 831–843, June 7, 2007 ª2007 Elsevier Inc. 833
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PRKCA in Mammalian Clock ResettingFigure 3. Photic Induction of Per1, Per2, and Dec1 Genes Is Comparable in Wild-Type and Prkca/ Animals
LD-entrained wild-type and mutant animals were exposed to a 15 min light pulse at ZT14 and sacrificed 45 min later. Upper panels show represen-
tative micrographs of emulsion ISH signal. Bar plots show quantification of mRNA induction by densitometric analysis of X-ray film contact autora-
diographs. The intensity of the signal of wild-type controls not exposed to light at ZT15 was set as 1. All data are mean ± SEM of three animals per
condition and genotype. Scale bars, 200 mm.extracts were prepared from the excised SCN, and en-
dogenous PER2 was pulled down with a PER2 antiserum.
The resulting immunoprecipitate was evaluated for the
presence of, and the interaction between, PER2 and
PRKCA by western blot analysis.
As shown in Figure 5A, actin levels were the same in all
samples, indicating that the extracts contained compara-
ble amounts of protein. Furthermore, PRKCA protein
levels in the SCN extract were not affected by light expo-
sure, indicating that PRKCA is neither induced nor de-
graded by light-signaling through the retinohypothalamic
tract. PER2 levels were also not significantly changed by
light exposure of the animal (Figure 7C, top panel and
open circles in Figure 7D), which is consistent with previ-
ous reports (Beaule´ et al., 2003; Field et al., 2000).
Next, PER2 immunoprecipitates were probed with
PRKCA antibodies in order to detect PER2/PRKCA com-
plex formation. Prior to light exposure, anti-PRKCA
antibodies revealed a weak band at 81 kDa, the predicted
size of PRKCA (Figure 5B, lane 1), indicating that a small
fraction PRKCA interacted with PER2. With progressively
longer light exposure, the intensity of the band represent-
ing PRKCA bound to PER2 became substantiallyaugmented, peaking at 40 min after the onset of light
exposure and rapidly downregulating thereafter
(Figure 5B, lanes 2–5). As expected, immunoprecipitates
from SCN extracts of Prkca/ mice were devoid of
a PRKCA band (Figure 5B, lane 6). Figure 5C is a quantita-
tive representation of three independent pull-down exper-
iments and illustrates the consistency of the results. When
animals were not exposed to light (sham control), the
amount of PRKCA-PER2 complex in the SCN (Figures
5D and 5E) was comparable to that seen at ZT14 prior
to applying light. When PRKCA antiserumwas used to im-
munoprecipitate proteins from SCN extracts, subsequent
western blot analysis with a PER2 antiserum revealed
a characteristic 130 kDa PER2 band (Figure 5F).
To address the issue of temporal specificity of PER2/
PRKCA complex formation, we exposed mice to light in
the late subjective day (CT8), when both PER2 (Figure 5G,
lane 1, and Field et al., 2000) and PRKCA (Figure 5G, lane
1) are expressed. Pull-downs with PER2 antiserum failed
to produce a band in the subsequent western blot probed
with a PRKCA antiserum (Figure 5H, lanes 2 and 3). Sham
animals yielded identical results (Figure 5H, lanes 4 and 5).
PER2 is neither significantly expressed nor light inducibleFigure 2. Photic Resetting of the Circadian Clock Is Impaired in Prkca-Deficient Mice
(A) Actograms (shading indicates darkness) of wild-type and Prkca/ animals.
(B) Average free-running period length (t) in DDwas 23.70 ± 0.07 hr (mean ±SEM) for wild-type animals (n = 19) and 23.76 ± 0.05 hr (n = 24) forPrkca/
mice (p > 0.05).
(C) Actograms of wild-type and Prkca/ animals maintained in LL of 100 lux.
(D) In LL, mutants had a significantly shorter t (24.91 ± 0.08 hr; n = 11) as compared with wild-type animals (25.18 ± 0.11 hr; n = 10; *p < 0.05).
(E and F) Double-plotted actograms of wild-type and Prkca-deficient mice exposed to a 400 lux/15 min light pulse (red asterisk) either in the early
(ZT14, E) or late (ZT22, F) night. Activity onsets are indicated by red lines; white and black horizontal bars on top indicate day and night, respectively.
(G) Photic phase response curves for wild-type and Prkca/ animals. Phase shifts at ZT14 were 1.01 ± 0.1 hr in wild-type animals and 0.52 ± 0.09 hr
in Prkca/mice. Data are presented as mean ± SEM (*p < 0.05, **p < 0.01; Student’s t test, n = 6 to 8).Neuron 54, 831–843, June 7, 2007 ª2007 Elsevier Inc. 835
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PRKCA in Mammalian Clock ResettingFigure 4. PRKCA and PER2 Proteins Interact in COS7 Cells
(A) PER2Myc, CRY2V5, and PRKCA were coexpressed in COS7 cells in the combinations noted in the header. Upper panel shows protein input; lower
panel depicts proteins that were immunoprecipitated followed by western blotting with antisera specified on the left margin.
(B) In vitro phosphorylation of PER2Myc by recombinant PRKCA and the effect of CRY2V5 and the PRKC inhibitor bisindolylmaleimide (Bis). Expected
positions of PER2Myc and CRY2V5 are indicated on the right.
(C) Efficient in vitro phosphorylation of PER2EGFP requires the addition of exogenous PRKCA protein.in the late subjective night (Field et al., 2000; Albrecht et al.,
1997; Shearman et al., 1997; Shigeyoshi et al., 1997; Ta-
kumi et al., 1998; Zylka et al., 1998), precluding interaction
studies at this time. We conclude that PER2 and PRKCA
interact in the SCN. This interaction is transient, light
induced, and restricted to the phase-delay period of the
circadian cycle. Because neither PER2 nor PRKCA con-
centrations in the SCN significantly change as a result of
light exposure, the formation of PER2/PRKCA complexes
is not a consequence of increased transcription or transla-
tion, but reflects a posttranslational process.
PRKCA Regulates the Nucleocytoplasmic
Distribution of PER2
A reduction in phase delay of locomotor activity, as
observed in Prkca-deficient mice, could arise from atten-
uation of the PER/CRY-mediated negative feedback that
these proteins exert on transcription of their own genes
(see Introduction). We therefore speculated that, following
light exposure, cytosolic PRKCAmay transiently retain the
PER2 protein outside the nucleus, thus transiently retard-
ing its negative feedback on CLOCK/BMAL1-mediated
transcription. Cultured cells are widely used to study the
dynamics of subcellular distribution of clock proteins
(Tamanini et al., 2005). We therefore transiently expressed
tagged PER2 (PER2Myc or PER2EGFP) with or without
PRKCA in COS7 or U2OS cells. In the absence of PRKCA,836 Neuron 54, 831–843, June 7, 2007 ª2007 Elsevier Inc.tagged PER2 was exclusively nuclear in %55% of cells,
while the remaining cells displayed cytoplasmic (25%–
35%) or mixed nuclear and cytoplasmic (20%–25%)
distributions (Figures 6A–6C). Coexpression with PRKCA
resulted in amarked drop (to as low as 10% in COS7 cells)
in the percentage of cells showing an exclusively nuclear
PER2 localization. This effect was abolished when PRKCA
was replaced by an enzymatically inactive mutant form of
the kinase (kdPRKCA). The latter data suggest that kinase
activity is required to retain PER2 in the cytoplasm.
The intracellular localization of PERproteins is regulated
by a nucleocytoplasmic shuttling mechanism involving
homo- and heteromeric complex formation (Chaves
et al., 2006; Yagita et al., 2002). To test whether such shut-
tling is affected by PRKCA, we treated COS7 cells coex-
pressing PER2EGFP and PRKCA with leptomycin B
(LMB), which promotes nuclear accumulation of PER2 by
blocking CRM1-mediated nuclear export (Yagita et al.,
2002). After LMB treatment, the fraction of PER2EGFP-
expressing cells with exclusively nuclear staining became
enriched in a time-dependent manner, with 80% of the
cells showing fluorescence in the nucleus 3 hr after initia-
tion of the treatment (Figures 6D and 6E). In the presence
of PRKCA, PER2EGFP still entered the nucleus, but this
occurred at a reduced efficiency, with only 45% of the
cells exhibiting nuclear green fluorescence 3 hr after
LMB application. These data suggest that PRKCA
Neuron
PRKCA in Mammalian Clock ResettingFigure 5. Transient Interaction of PRKCA and PER2 in the SCN Induced by Light Exposure at ZT14
Animals entrained to LD 12:12were exposed to light pulses (400 lux) of progressively longer duration, starting at ZT14. Sham controls were kept under
the same conditions but did not receive any nocturnal light. (A) Western blotting and probing with PRKCA or actin antisera reveals constant levels of
these proteins in the SCN of wild-type mice (lanes 1–5). No PRKCA signal was detected in Prkca/ SCN extract (lane 6). (B) Protein extracts were
immunoprecipitated with PER2 antibodies, western blotted, and probed for PRKCA. Note a transient interaction of two proteins peaking at 40min. (C)
Densitometric quantifications of three independent experiments of the type shown in (B). For calculation of relative signal strength, see Experimental
Procedures. Data are presented as mean ± SEM (*p < 0.05, Student’s t test). (D and E) Without light exposure (sham control), immunoprecipitation of
SCN extracts with PER2 followed by western blotting with PRKCA antiserum yields a weak signal, indicating that PER2-PRKCA interaction is light
evoked. (F) Immunoprecipitation of SCN extracts from light-exposed mice with a PRKCA antiserum followed by western blotting with the PER2 an-
tibody used for immunoprecipitation in the experiments shown in (B)–(E) yields a strong band at t = 40 min (lane 2). Reminiscent of the data shown in
Figure 5B (lane 1), a weak band is seen prior to application of a light pulse. (G and H) Mice kept in DD and exposed to light at CT8 show no interaction
between PER2 and PRKCA (H). Lane 1 represents SCN prior to light exposure. Lanes 2 and 3 are from SCNs of mice exposed to 40 or 80 min of light.
Lanes 4 and 5 are sham controls. The input panel (G) demonstrates that PER2 and PRKCA were both present in the SCN extract.regulates the kinetics of nuclear import of PER2 protein. A
mechanism inwhich PRKCA enhances cytoplasmic reten-
tion of PER2 is consistent with the resetting phenotype of
Prkca/ mice. Without PRKCA, the cytoplasmic pool of
PER2 would be depleted more rapidly, the negative feed-
back shortened, and hence, the light-induced phase delay
reduced.
PRKCA Controls the Stability of PER2
In addition to its regulation of the kinetics of nuclear im-
port, one can envisage additional mechanisms by which
PRKCA may modulate the negative feedback loop of the
circadian clockwork. Casein kinase 13 (CK13) is known
to phosphorylate PER proteins and influence the period
length of the TTL by regulating not only the nuclear import,
but also the stability, of PER proteins (Akashi et al., 2002;
Eide et al., 2005; Takano et al., 2000; Vanselow et al.,
2006; Vielhaber et al., 2000). To test whether PRKCA
affects PER2 stability, HEK293 cells were transfectedwith either PER2EGFP alone or PER2EGFP and PRKCA.
After blocking de novo protein synthesis with cyclohexi-
mide (CHX), cellular levels of PER2 were determined by
western blotting (Figure 7A). This data showed that
PRKCA stabilizes PER2. As can be calculated from the
decay curves (Figure 7B), the presence of PRKCA ex-
tended the half-life of PER2EGFP from 12.8 ± 2.3 hr to
38.6 ± 4 hr. These transient expression studies provide ev-
idence that PRKCA stabilizes PER2 protein in cell cultures.
To test whether PRKCA has a similar stabilizing influ-
ence on PER2 in the SCN, we measured PER2 protein
levels after light exposure in Prkca/ mice. For this we
used the same experimental paradigm as for the analysis
of light-evoked PRKCA/PER2 interaction. Western blot
analysis revealed comparable amounts of PER2 protein
in wild-type andmutant animals at ZT14, prior to exposure
to the light pulse (Figures 7C and 7D). Consistent with pre-
vious reports (Beaule´ et al., 2003; Field et al., 2000), light
exposure of wild-type animals did not significantly affectNeuron 54, 831–843, June 7, 2007 ª2007 Elsevier Inc. 837
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PRKCA in Mammalian Clock ResettingFigure 6. PRKCA Controls Nuclear Import of PER2 Protein
(A–C) Quantitative representation of subcellular distribution of tagged PER2 alone and in the presence of PRKCA or kinase-dead PRKCA (kdPRKCA).
Percentage of COS7 (A and C) or U2OS (B) cells showing nuclear (N), nuclear and cytoplasmic (N/C), or cytoplasmic (C) localization of tagged PER2 is
shown.
(D and E) Blocking nuclear export in COS7 cells with leptomycin B (LMB) leads to a time-dependent enrichment of PER2EGFP in the nucleus. (D) Rep-
resentative micrographs of PER2EGFP (green) and PRKCA (red) immunofluorescence before and after LMB treatment, respectively. (E) Bar plots are
quantifications of experiments as shown in (D). All bar plots are derived from a field of 100 cells in three independent assays.the amount of PER2 in the SCN. However, western blot
analysis uncovered a marked time-dependent reduction
of PER2 protein in the SCN of Prkca/ animals
(Figure 7C, quantified in Figure 7D).
Taken together, these data demonstrate that PRKCA
stabilizes PER2 after light exposure in vivo. The reduction
of such stabilization in the absence of PRKCA is consis-
tent with the resetting phenotype of Prkca/ mice in
that having fewer PER2 molecules in SCN neurons of
light-exposed mice would attenuate the negative feed-
back and hence reduce the magnitude of phase delay.
DISCUSSION
In mammals, photic resetting of the circadian oscillator in
the SCN involves CREB-mediated transcriptional activa-
tion of certain clock genes (Travnickova-Bendova et al.,838 Neuron 54, 831–843, June 7, 2007 ª2007 Elsevier Inc.2002). Our current findings, obtained using mice with
a loss-of-functionmutation in theprotein kinaseCa (Prkca)
gene, shed new light on photic entrainment of the mam-
malian circadian clock. We have shown that Prkca/
animals fail to properly reset their circadian clock in
response to a light pulse given at ZT14 and that the under-
lying defect does not involve light/CREB-mediated
transcriptional activation. Instead, as discussed in detail
below, we have provided in vitro and in vivo evidence
that PRKCA transmits the light signal through posttransla-
tional mechanisms affecting the negative limb of the TTLs
that lie at the heart of the circadian clock.
PRKCA and CREB Operate by Different Pathways
The Prkca-deficient mice’s attenuation of clock resetting
in response to light exposure during the early night is rem-
iniscent of that observed in the CREBS142A mutant mouse
Neuron
PRKCA in Mammalian Clock ResettingFigure 7. PRKCA Stabilizes PER2
(A) Western blotting of HEK293 cell extracts showing the rate of degradation of PER2EGFP in the absence (top panel) and presence (lower panel) of
PRKCA. Duration of cycloheximide (CHX) treatment and antibody used are indicated.
(B) Quantification of western blots (n = 3). PER2EGFP levels were normalized to actin and the amount of PER2EGFP present at the onset of CHX treat-
ment (0 hr) was set to 100%. All data presented are mean ± SEM.
(C) Levels of endogenous PER2 in SCN extracts of wild-type and Prkca/mice exposed to a progressively longer light pulse beginning at ZT14. The
PER2 antiserum used detects a single band at 130 kDa.
(D) Quantification of western blots (n = 3). PER2 levels were normalized to those of actin and the amount of PER2 detected at ZT14 was set to 100%.
All data presented are mean ± SEM.model, raising the possibility that PRKCA, similar to other
kinases, resides in a pathway converging on CREB. In an-
imals homozygous for the CREBS142A point mutation, as
well as in animals in which the CREB signaling cascade
was compromised by other means, a light pulse de-
creases the induction of Per gene transcription (Dziema
et al., 2003; Gau et al., 2002; Oster et al., 2003; Paul
et al., 2003; Yokota et al., 2001). By contrast, we found
that the extent of light induction of three different clock
genes—Per1, Per2, and Dec1—in wild-type and Prkca/
mice was very similar. These data led us to conclude
that the CREB pathway is still fully functional in Prkca-
deficient mice and presumably accounts for the residual
phase delay of 30 min seen in Prkca/ animals, and
that the photic resetting mechanism involving PRKCA is
accordingly different from that mediated by CREB.
PRKCA Functions through Interaction with, and
Protection of, PER2
In search of a mechanism of action of PRKCA in photic
resetting, we discovered a transient interaction between
PRKCA and PER2 in the SCN of light-pulsed mice. It
appears that the amount of PER2/PRKCA complex inthe SCN parallels the magnitude of behavioral phase shift;
the longer the pulse, the more extensive the formation of
PER2/PRKCA complexes, the larger the shift. After
a very long light pulse, however, the amount of PER2/
PRKCA complexes is reduced again. This observation
parallels a basic feature of all known circadian clocks,
which is that even though initially the amplitude of behav-
ioral phase shifts is directly proportional to the overall
quantity of stimulation with light (irradiance), saturation is
observed with longer exposure times (Dkhissi-Benyahya
et al., 2000; Foster et al., 1991; Nelson and Takahashi,
1991; Yoshimura and Ebihara, 1998).
In the absence of PRKCA, the PER2 protein in the SCN
is degraded after exposure of the animal to light. This pro-
cess occurs on a timescale that is similar to that seen for
PER2/PRKCA complex formation, which raises the possi-
bility that the interaction with PRKCA protects PER2 from
being degraded by the proteasome. PRKCA-mediated
stabilization of PER2 was also observed in cultured cells,
albeit the protective effect was less obvious than in the
SCN, possibly due to the presence of the EGFP tag. We
found no evidence that PRKCA is required for PER2
stabilization during the normal circadian cycle. Thus,Neuron 54, 831–843, June 7, 2007 ª2007 Elsevier Inc. 839
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into effect only after phase-delaying light pulsing. There
are several examples wherein complex formation of clock
proteins assists stabilization of complex constituents. For
instance, the stability of PER2 during the circadian cycle is
regulated by the formation of a PER2/CRY complex en-
riched in the nucleus (Kume et al., 1999; Shearman
et al., 2000; Yagita et al., 2002). Similarly, the stability
and nuclear localization of CLOCK depends on the inter-
action with BMAL1 (Kondratov et al., 2003). Additional
stabilizing components in a PER2/PRKCA complex may
be CRY proteins.
A Model of PRKCA Function in Photic Regulation
of the Circadian Clock of Mammals
Irrespective of the details of the composition of a PER2/
PRKCA complex, our data led us to suggest the following
scenario through which PRKCA might affect entrainment
of the circadian pacemaker. At the onset of (the subjec-
tive) night, SCN cells express high levels of PER and
CRY that together represent the negative limb of the circa-
dian feedback loop. Providing a light pulse to a mouse at
this time of the day results in the formation of a pool of
PER2/PRKCA (and possibly PER2/CRY/PRKCA) in the
cytoplasm. In this complex, PRKCA stabilizes PER2 as
our biochemical data in Prkca mutant mice show. This
combination of a transient stabilization and cytoplasmic
retention of PER2 has the effect of prolonging the negative
feedback. Hence, reactivation of the positive limb of the
circadian clock (CLOCK and BMAL1) is delayed. At the
behavioral level, this prolongation of the negative feed-
back causes a phase delay on the day following the light
pulse. Our model would predict that if cytoplasmic reten-
tion and stabilization of PER2 were reduced—as is the
case in Prkca/ mice—the magnitude of light-induced
phase delays should be smaller, which is what we
observed.
PRKCA is not the sole kinase phosphorylating PER pro-
teins (Xu et al., 2007 and references therein), and con-
versely, PERs are not the sole PRKC targets (e.g., Shim
et al., 2007). The emblematic tau hamster carries a point
mutation in the casein kinase 1 epsilon gene (Csnk1e)
and is characterized by a shortened period length (Ralph
et al., 1990) and, as shown in an in vitro assay, increased
degradation of PER1 and PER2 (Gallego et al., 2006). By
contrast, the stabilization of PER2 by PRKCA has no con-
sequences on the period length, but rather plays a role in
photic clock resetting. Glycogen synthase kinase-3b also
phosporylates PER2 in vitro (Iitaka et al., 2005). Whether
this translates into a circadian phenotype is not known.
PRKCA and PRKCG can phosphorylate CLOCK, and
kinase inhibitor studies in NIH3T3 cells suggest that
CLOCK mediates phase resetting in these cells through
the activation of Per1 (Shim et al., 2007).
The clock of Neurospora crassa provides a remarkable
analogy to our finding of a posttranslational role of
a PRKC in photic entrainment (Franchi et al., 2005). During
the dark phase the Neurospora transcription factor840 Neuron 54, 831–843, June 7, 2007 ª2007 Elsevier Inc.‘‘white-collar-1’’ (WC1), which regulates expression of
the light-inducible clock gene frequency, is associated
with PRKC. A light pulse evokes a rapid dissociation of
the kinase from WC1, followed by the activation of the
frequency gene (Franchi et al., 2005). Although in mam-
mals, PRKCA binds to the core clock component PER2
as a result of photic stimulation, while in Neurospora,
PRKC dissociates from WC1, regulation is posttransla-
tional in both species and brings about clock resetting.
Taken together, our work affirms the existence of post-
translational mechanisms controlling light entrainment of
the circadian clock in mammals, and thus demonstrates
the evolutionary conservation of this type of regulation
among all organisms that have a circadian clock.
EXPERIMENTAL PROCEDURES
Animals
Behavioral monitoring was performed as described (Jud et al., 2005).
For all experiments 129/Sv wild-type mice and Prkca-deficient mice
of the same genetic background were used. All animals subjected to
behavioral experiments were males of at least 3 months of age. Mice
were sacrificed by cervical dislocation and decapitated under a 15W
safety red light. Animal studies were in compliance with the German
Law on Animal Welfare.
Behavioral Recording
Individually housed Prkca/mutant mice and age-matched wild-type
controls were entrained for 8 to 10 days to an LD 12:12 (400 lux) cycle
before transfer to DD or LL (100 lux). Locomotor activity was analyzed
using ClockLab (Actimetrics). To determine the circadian period of the
locomotor activity rhythm, we used c2-periodogram analysis. For the
photic phase-shifting experiments, entrained mice received a light
pulse of 400 lux for the indicated duration at specified time points on
the last night in LD or the first day in DD and were subsequently
released into DD for 7 to 9 days (Aschoff’s type II protocol). Phase
shifts were quantified as described in Oster et al. (2002).
In Situ Hybridization
DNA templates for Prkca (nts 2318-2847; NM_011101) and Dec1 (nts
298-1517; NM_011492) were generated by PCR from mouse brain
cDNA (Yaylaoglu et al., 2005). Templates for Per1 and Per2 were as
described (Albrecht et al., 1997). ISH with 35S-labeled antisense RNA
probes was carried out on 8 mm paraffin coronal sections through
the SCN. Adjacent sections were hybridized with sense probes. Quan-
tification of expression strength was performed using Kodak BioMax
MS film (Albrecht et al., 1997; Oster et al., 2002).
Western Blot and Immunoprecipitation from SCN Tissue
Mice were exposed to a 400 lux light pulse of 0, 10, 20, 40, or 80 min at
ZT14 or CT8, and brains were removed when the pulse was finished.
SCNsweremicrodissected from 1mm thick coronal slices. Sham con-
trols were treated identically. SCNs from two mice were pooled and
homogenized in lysis buffer (150 mM NaCl, 20 mM HEPES, 1 mM
MgCl2, 1mMEGTA, 1mMDTT, and protease inhibitor cocktail [Sigma]
[pH 7.4]). After centrifugation supernatants were boiled for 10 min in
SDS sample buffer and separated by 8%SDS-PAGE. For immunopre-
cipitation, protein A agarose beads were preincubated for 1 hr at 4C
with mPER2 antibody (1:50, Alpha Diagnostic International) or with
PRKCA antibody (1:50, Cell Signaling). Thereafter, 20 mg SCN lysate
protein was added, followed by overnight incubation at 4C, centrifu-
gation, and washing with PBS. Beads were eluted with Triton X-100-
free lysis buffer, and eluates were boiled for 10 min and separated
on 8% SDS-PAGE. After transfer to PVDF membranes and blocking
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anti-PER2 antibody, 1:500; anti-PRKCA, 1:1000; anti-actin antibody,
1:2000, Santa Cruz; and secondary goat anti-rabbit antiserum,
1:20,000, Jackson Labs. Detection: Supersignal Westpico or Femto
(Pierce). Signal was quantified using computer-assisted densitometry
(ImageJ). PER2 and PRKCA bands were normalized to those of actin.
Relative strength of PRKCA/PER2 interaction at ZT14 was set as 1.
Western Blots and Immunoprecipitation from Cells
COS7 cells (DMEM, 10%FCS) were seeded in 10 cmdishes at 1.8–23
106 and transfected (Lipofectamine PLUS, LifeTech or Effectene, Qia-
gen) 16 hr later with plasmids expressing PER2Myc, CRY2V5, or
PRKCA. Expression vectors were pcDNA3.1/V5-His-TOPO and
pcDNA3.1/Myc-His A (Invitrogen). Twenty-four hours later, cells were
lysed (lysis buffer: 1% Triton X-100, 50 mM Tris [pH 7.5], 150 mM
NaCl, 1 mM EGTA, 1 mM EDTA, 10 mM b-glycerophosphate, 10 mM
b-mercaptoethanol, 1 mMNaF, 10 mg/ml aprotinin, 10 mg/ml leupeptin,
1 mM PMSF, 1 mM Na-orthovanadate). For immunoprecipitations
1 mg of total lysate was incubated with 20 ml of protein G agarose
beads (Roche) for 30min at 4C for removing proteins binding nonspe-
cifically. Samples were centrifuged and supernatants were incubated
overnight at 4C with 1 mg of rabbit polyclonal anti-PRKCA (Santa-
Cruz). Forty microliters of protein G beads (preblocked in 2% BSA/
PBS) in lysis buffer were added to the samples. This mixture was fur-
ther incubated for 2 hr at 4C and centrifuged, and beads were washed
four times in lysis buffer. Dry beads were resuspended in 2 3 SDS
loading buffer, boiled, centrifuged, and analyzed by SDS-PAGE and
western blotting using PVDF membranes. Sequential detection of
proteins was performed, andfilters were stripped in between with
0.2 N sodium hydroxide. Antibodies were as follows: anti-Myc
antibodies, 1:5000; anti-V5 antibodies, 1:3000, both Invitrogen; anti-
PRKCA antibodies, 1:1000, Santa Cruz; secondary anti-mouse or
rabbit HRP-conjugated, 1:20,000, Jackson Labs. Detection was by
chemiluminescence (Supersignal Westpico, Pierce).
For stability studies of PER2, HEK293 cells (DMEM, P/S, 10% FCS)
were transfected (Fugene, Boehringer) with PER2EGFP (Yagita et al.,
2002) and PRKCA in 60 mm dishes. Cells were trypsinized after 24
hr, equally divided in four 60 mm dishes, and cultured over night.
CHX (in ethanol) was added to the cells (100 mg/ml final concentration)
and after 2, 4, or 6 hr, cells were lysed with 1 3 SDS loading buffer.
PER2EGFP and actin were detected on same western blot by chemilu-
minescence (Renaissancewestern blot reagent plus, NEN). Antibodies
were as follows: anti-EGFP antibodies, 1:1000, Roche; anti-actin anti-
bodies, 1:3000, Chemicon; secondary anti-mouse HRP-conjugated,
1:1000, Dako.
Cell Culture and Immunofluorescence
Immunofluorescence techniques were performed as described (Yagita
et al., 2002). Proteins were expressed in COS7 or U2OS cells (grown in
McCoy’s 5amediumwith 1.5 mML-glutamine, 10% FCS). The subcel-
lular localization of PER2Myc or PER2EGFP, singly and double trans-
fected with PRKCA or kdPRKCA, was analyzed 24 hr after transfection
and scored in at least two independent experiments. The cellular local-
izations of the proteins did not vary between 24 hr and 48 hr after trans-
fection. Cells were fixed in 4% paraformaldehyde, washed in PBS, and
permeabilized in 0.1% Triton X-100 (10 min each step). Primary anti-
bodies were as follows: mouse anti-Myc (1:650); rabbit anti-PRKCA
(1:250 or 1:1000). Secondary antibodies were as follows: FITC-conju-
gated anti-mouse and TRITC-conjugated anti-rabbit IgG (Sigma). In
the case of COS7 cells expressing PER2EGFP, the secondary antibody
wasanti-rabbit Alexa594 (1:1000,Molecular Probes). LMB (Sigma) dis-
solved inmethanol was added to themedium at a final concentration of
10 ng/ml, and cells were incubated for 1.5 hr and 3 hr before fixation.
Kinase Assay
PER2Myc, PER2EGFP, and CRY2V5 proteins alone or in combination
were expressed in COS7 cells and isolated by immunoprecipitationwith anti-Myc or anti-V5 antibodies (1:650) absorbed to protein G aga-
rose beads. Pull-downs were washed twice in kinase buffer (20 mM
Tris [pH 7.5], 2 mM MgCl2, 0.1% NP40, 1 mM Na2VO4, 10 mg/ml
leupeptin, 0.5 mM DTT). The kinase reaction was performed for
30 min at room temperature with recombinant PRKCA, an aliquot of
the pull-down, 100 mM CaCl2, 1 mM ATP, and 5 mCi g
32P-ATP
(3000 Ci/mmol, NEN) in presence or absence of 1 mM bisindolylmalei-
mide. The reaction was stopped by adding loading buffer and boiling
for 5 min at 95C. Twenty-five microliters were loaded into a twelve
percent SDS-PAGE and visualized by autoradiography.
Statistical Analysis
In all experiments, statistical significance, with p < 0.05 as the criterion
of significance, was determined using unpaired two-tailed Student’s
t tests and GraphPad Prism Software (GraphPad Software, San Diego,
CA). (*) and (**) indicate p < 0.05 and p < 0.01 versus control,
respectively.
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